Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neonatology | 3 | 2022 | 140 | 1.050 |
Why?
|
| Infant, Premature | 3 | 2022 | 2092 | 0.830 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2023 | 83 | 0.830 |
Why?
|
| Burnout, Professional | 2 | 2022 | 702 | 0.820 |
Why?
|
| Premature Birth | 1 | 2022 | 1771 | 0.760 |
Why?
|
| Rare Diseases | 2 | 2023 | 619 | 0.710 |
Why?
|
| Minority Health | 1 | 2021 | 81 | 0.700 |
Why?
|
| Health Status Disparities | 3 | 2021 | 1830 | 0.660 |
Why?
|
| Faculty | 1 | 2022 | 383 | 0.650 |
Why?
|
| Healthcare Disparities | 4 | 2022 | 3388 | 0.620 |
Why?
|
| Mentors | 1 | 2022 | 661 | 0.560 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 601 | 0.510 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2022 | 833 | 0.500 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2015 | 84 | 0.490 |
Why?
|
| Karyotyping | 1 | 2015 | 1171 | 0.430 |
Why?
|
| Patient Participation | 1 | 2021 | 1439 | 0.400 |
Why?
|
| Language | 1 | 2021 | 1533 | 0.390 |
Why?
|
| Genetic Testing | 2 | 2023 | 3531 | 0.370 |
Why?
|
| Critical Illness | 1 | 2022 | 2709 | 0.320 |
Why?
|
| Infant, Newborn | 8 | 2023 | 26181 | 0.300 |
Why?
|
| Genetic Variation | 1 | 2020 | 6551 | 0.250 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 1394 | 0.240 |
Why?
|
| Internship and Residency | 2 | 2022 | 5870 | 0.240 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5397 | 0.210 |
Why?
|
| Pandemics | 1 | 2021 | 8624 | 0.180 |
Why?
|
| Economics | 1 | 2021 | 141 | 0.180 |
Why?
|
| Community-Based Participatory Research | 1 | 2021 | 226 | 0.160 |
Why?
|
| Patient Discharge | 2 | 2022 | 3476 | 0.160 |
Why?
|
| Organizational Policy | 1 | 2021 | 429 | 0.160 |
Why?
|
| Infant | 5 | 2023 | 36060 | 0.150 |
Why?
|
| Curriculum | 2 | 2022 | 3718 | 0.150 |
Why?
|
| Peer Group | 1 | 2022 | 674 | 0.140 |
Why?
|
| Humans | 20 | 2023 | 760621 | 0.140 |
Why?
|
| Aftercare | 1 | 2022 | 916 | 0.130 |
Why?
|
| Empathy | 1 | 2020 | 473 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2015 | 286 | 0.120 |
Why?
|
| Birth Weight | 1 | 2023 | 2097 | 0.120 |
Why?
|
| Pregnancy | 3 | 2023 | 29749 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2015 | 238 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2015 | 385 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1348 | 0.110 |
Why?
|
| Minority Groups | 1 | 2021 | 1201 | 0.110 |
Why?
|
| Research | 1 | 2021 | 1974 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2021 | 1940 | 0.090 |
Why?
|
| Mothers | 1 | 2021 | 2186 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 39261 | 0.090 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2907 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3598 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 1764 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2022 | 3865 | 0.080 |
Why?
|
| Female | 7 | 2023 | 391270 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2677 | 0.080 |
Why?
|
| Carboplatin | 1 | 2011 | 788 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3775 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3310 | 0.070 |
Why?
|
| Sleep | 1 | 2022 | 4751 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5325 | 0.070 |
Why?
|
| Risk Factors | 1 | 2020 | 74359 | 0.060 |
Why?
|
| Pediatrics | 1 | 2020 | 3586 | 0.060 |
Why?
|
| Genome, Human | 2 | 2015 | 4417 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15289 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 15789 | 0.060 |
Why?
|
| Child | 2 | 2022 | 79806 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3616 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2020 | 24123 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17790 | 0.040 |
Why?
|
| Adult | 1 | 2021 | 219994 | 0.040 |
Why?
|
| United States | 2 | 2023 | 72461 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4878 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 80372 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3315 | 0.030 |
Why?
|
| Male | 1 | 2015 | 359744 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1869 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2514 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5794 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3986 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 169152 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6544 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15620 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9411 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8515 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 16939 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12626 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 29658 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13630 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2011 | 65017 | 0.000 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_